GNI Group Past Earnings Performance
Past criteria checks 1/6
GNI Group has been growing earnings at an average annual rate of 50.2%, while the Biotechs industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 25.1% per year.
Key information
50.2%
Earnings growth rate
48.3%
EPS growth rate
Biotechs Industry Growth | 31.9% |
Revenue growth rate | 25.1% |
Return on equity | -0.3% |
Net Margin | 4.1% |
Last Earnings Update | 31 Dec 2024 |
Recent past performance updates
GNI Group's (TSE:2160) Weak Earnings May Only Reveal A Part Of The Whole Picture
Feb 26GNI Group's (TSE:2160) Shareholders Should Assess Earnings With Caution
Aug 27Recent updates
GNI Group's (TSE:2160) Weak Earnings May Only Reveal A Part Of The Whole Picture
Feb 26GNI Group Ltd.'s (TSE:2160) Shares Leap 25% Yet They're Still Not Telling The Full Story
Feb 21GNI Group Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Feb 18After Leaping 48% GNI Group Ltd. (TSE:2160) Shares Are Not Flying Under The Radar
Sep 20GNI Group's (TSE:2160) Shareholders Should Assess Earnings With Caution
Aug 27GNI Group Ltd. (TSE:2160) Stock's 37% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 06Investors Continue Waiting On Sidelines For GNI Group Ltd. (TSE:2160)
Jun 20Is GNI Group (TSE:2160) Using Too Much Debt?
Apr 12News Flash: Analysts Just Made An Incredible Upgrade To Their GNI Group Ltd. (TSE:2160) Forecasts
Mar 19Further Upside For GNI Group Ltd. (TSE:2160) Shares Could Introduce Price Risks After 40% Bounce
Feb 28Revenue & Expenses Breakdown
How GNI Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 24 | 23,612 | 978 | 15,772 | 2,812 |
30 Sep 24 | 22,655 | 7,186 | 16,609 | 2,709 |
30 Jun 24 | 23,647 | 6,766 | 16,231 | 2,723 |
31 Mar 24 | 27,752 | 9,550 | 15,935 | 2,610 |
31 Dec 23 | 26,010 | 8,094 | 15,293 | 2,557 |
30 Sep 23 | 25,204 | 1,525 | 13,024 | 2,502 |
30 Jun 23 | 23,360 | 1,370 | 12,379 | 2,709 |
31 Mar 23 | 17,691 | 35 | 11,154 | 2,712 |
31 Dec 22 | 17,418 | 388 | 10,966 | 2,545 |
30 Sep 22 | 15,915 | 848 | 9,953 | 2,417 |
30 Jun 22 | 14,379 | 801 | 9,047 | 2,240 |
31 Mar 22 | 12,751 | 985 | 8,223 | 2,080 |
31 Dec 21 | 12,690 | 1,066 | 7,959 | 2,015 |
30 Sep 21 | 12,356 | 2,086 | 7,188 | 1,805 |
30 Jun 21 | 11,858 | 1,955 | 6,645 | 1,525 |
31 Mar 21 | 11,520 | 1,558 | 6,252 | 1,438 |
31 Dec 20 | 9,773 | 1,258 | 5,180 | 1,243 |
30 Sep 20 | 9,066 | 367 | 4,806 | 1,056 |
30 Jun 20 | 8,407 | 247 | 4,502 | 1,036 |
31 Mar 20 | 7,996 | 194 | 4,498 | 839 |
31 Dec 19 | 7,446 | 181 | 4,334 | 758 |
30 Sep 19 | 6,734 | 147 | 3,853 | 658 |
30 Jun 19 | 6,279 | 154 | 3,706 | 585 |
31 Mar 19 | 5,581 | 258 | 3,290 | 567 |
31 Dec 18 | 5,018 | -200 | 2,998 | 530 |
30 Sep 18 | 4,802 | 47 | 2,730 | 527 |
30 Jun 18 | 4,095 | -130 | 2,401 | 413 |
31 Mar 18 | 3,310 | -337 | 2,103 | 302 |
31 Dec 17 | 2,648 | -175 | 1,740 | 268 |
30 Sep 17 | 1,939 | -97 | 1,521 | 243 |
30 Jun 17 | 1,473 | -111 | 1,261 | 238 |
31 Mar 17 | 1,347 | -406 | 1,139 | 257 |
31 Dec 16 | 1,306 | -513 | 1,118 | 274 |
30 Sep 16 | 1,117 | -858 | 878 | 580 |
30 Jun 16 | 1,073 | -956 | 979 | 519 |
31 Mar 16 | 1,093 | -752 | 1,048 | 452 |
31 Dec 15 | 1,016 | -623 | 1,049 | 379 |
30 Sep 15 | 928 | -440 | 1,071 | 139 |
30 Jun 15 | 814 | -360 | 963 | 139 |
31 Mar 15 | 651 | -345 | 823 | 139 |
31 Dec 14 | 474 | -327 | 715 | 139 |
30 Sep 14 | 334 | -527 | 364 | 427 |
30 Jun 14 | 254 | -787 | 511 | 427 |
31 Mar 14 | 202 | -769 | 438 | 427 |
Quality Earnings: 2160 has a high level of non-cash earnings.
Growing Profit Margin: 2160's current net profit margins (4.1%) are lower than last year (31.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2160's earnings have grown significantly by 50.2% per year over the past 5 years.
Accelerating Growth: 2160's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 2160 had negative earnings growth (-87.9%) over the past year, making it difficult to compare to the Biotechs industry average (9%).
Return on Equity
High ROE: 2160's Return on Equity (-0.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/03/15 19:39 |
End of Day Share Price | 2025/03/14 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
GNI Group Ltd. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Stephen Barker | Jefferies LLC |
Yuriko Ishida | Mizuho Securities Co., Ltd. |
Nia Dokova | Pelham Smithers Associates Ltd. |